Everand Logo

Welcome to Everand!

  • STAT

    HHS opens door to possibility of importing some drugs to drive down prices

    In an early but striking move, the Trump administration is opening the door to possibility of importing drugs in limited cases.
    by Erin Mershon Jul 19, 2018 2 minutes
    Secretary of Health and Human Services Alex Azar

    WASHINGTON — The Trump administration is opening up the door to importing prescription drugs — at least in a limited number of cases.

    The administration said Thursday that the Department of Health and Human Services will form a working group to look at the idea of in cases in which there is a dramatic price increase for a drug produced by one manufacturer and not protected by patents

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT1 min read
    STAT+: Senate Drug Shortage Bill Would Pay Hospitals Bonuses For Good Contracting Practices
    A bipartisan Senate bill takes a new approach to persistent drug shortages: have Medicare pay bonuses to hospitals and physicians for contracting that ensures a steady supply.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About GLP-1 Spending, Biosimilar Patient Costs, And More
    Spending on GLP-1 drugs like Ozempic and Wegovy ballooned last year and they're set to cost the U.S. health care system and the federal government still more.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About FTC Fighting ‘Junk’ Patents, Pfizer Direct-to-consumer Plans, And More
    The FTC expanded its campaign against pharmaceutical companies for filing what it calls “junk” patent listings for 20 different brand-name treatments.

    Related Books & Audiobooks